ErbB2amp ducts invaded more slowly, consistent with recent studies that suggest ErbB2-amplified ductal carcinoma in situ may take longer to progress despite ultimately more aggressive behavior49. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.